GlassScriptPhysician profile
Amanda J Tuttle
NPI 1932665221
$2,213.77
in general payments reported to CMS, 2019-2025
23 companies · $372 in 2025
The $372 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $202 · 2022: $653 · 2023: $496 · 2024: $491 · 2025: $372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,260 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,260.14 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $497.57 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $380.44 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $245.37 | 2023-2025 | Myfembree, Gemtesa |
| Aspira Women'S Health INC | $170.08 | 2021-2022 | |
| Scynexis, INC. | $111.13 | 2022 | |
| Millicent US INC | $102.15 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Mayne Pharma Commercial LLC | $101.21 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $97.88 | 2022-2023 | |
| Pfizer INC. | $85.06 | 2021-2025 | |
| Organon LLC | $63.21 | 2023-2025 | Nexplanon |
| Ethicon US, LLC | $49.73 | 2021-2022 | |
| Myovant Sciences INC. | $42.83 | 2021-2022 | |
| Agile Therapeutics, INC. | $38.83 | 2021-2024 | Twirla |
| Shield Therapeutics INC | $36.85 | 2025 | |
| Therapeuticsmd, INC. | $30.86 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $29.85 | 2025 | Novasure |
| Conmed Corporation | $23.82 | 2024 | Airseal |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.78 | 2023 | Xifaxan, Trulance |
| Exeltis, USA INC. | $23.07 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $20.77 | 2023 | Exparel |
| Biosense Webster, INC. | $13.94 | 2023 | Carto 3 |
| Baxter Healthcare | $13.53 | 2022 | |
| Amgen INC. | $11.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Tuttle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.